← Back to Search

Procedure

Microwave Ablation for Lung Cancer (MARK 1A Trial)

N/A
Waitlist Available
Led By Shanda Blackmon, MD, MPH
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

Does lung ablation improve clinical outcomes for patients deemed to be surgically high-risk?

Eligible Conditions
  • Lung Cancer
  • Lung Metastasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assessment of patient adverse events as defined by CTCAE.
Efficacy of microwave ablation.
Secondary study objectives
Pathological response in patients receiving microwave ablation.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Microwave AblationExperimental Treatment1 Intervention
Microwave Ablation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Microwave ablation
2011
N/A
~660

Find a Location

Who is running the clinical trial?

Medtronic - MITGIndustry Sponsor
262 Previous Clinical Trials
300,769 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,339 Previous Clinical Trials
3,062,136 Total Patients Enrolled
Shanda Blackmon, MD, MPHPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
11 Total Patients Enrolled
~1 spots leftby Nov 2025